parC mutants were selected, and resistance could be transferred from DNA from S. oralis, S. mitis, S. sanguis, and S. constellatus to S. pneumoniae, with frequencies of 10 Ϫ3 to !10 Ϫ7 in correlation with the homologies of their quinolone resistance determining region sequences (95%, 91%, 85%, and 81%, respectively). Reciprocal transfers of mutated parC from DNA from S. pneumoniae to S. mitis and S. oralis were also observed. Simultaneous transfer of mutated parC and gyrA genes from S. mitis to S. pneumoniae yielded high-level-resistant pneumococcal transformants in one step at low frequencies. The parE-parC region of the type strain S. mitis 103335 T had 190% homology with that of S. pneumoniae. The efficient interspecific transfer of quinolone resistance determinants in vitro leads us to anticipate their dissemination in the clinical setting.
Streptococcus pneumoniae is one of the most important respiratory tract pathogens and is the leading cause of communityacquired pneumonia. Spread of penicillin resistance [1] has motivated the search for alternative antibiotics for the treament of pneumococcal infections. Fluoroquinolones (FQs), such as ciprofloxacin, were proposed, but therapeutic failures and selection of resistant mutants were soon reported [2] , and the trend is now to develop extended-spectrum FQs active against S. pneumoniae, such as trovafloxacin and grepafloxacin [3] .
Two main mechanisms of FQ resistance in S. pneumoniae, that is, target alteration and increased efflux, have been reported in several instances [4] [5] [6] [7] [8] . Altered topoisomerase IV or gyrase have been reported by many authors in resistant clinical isolates, as well as in laboratory mutants [3] [4] [5] [6] [7] . Target mutations take place essentially in the so-called quinolone resistance determining region (QRDR) [9] . Whereas alterations of a single target generally lead to a low-level resistance to the newer FQs, high-level resistance is obtained only when both targets are modified [3, 4, 7] .
In S. pneumoniae, which is naturally transformable in vivo, resistance to b-lactam antibiotics is mainly due to penicillinbinding protein (PBP) alterations resulting from genetic exchanges with commensal viridans streptococci of the oral flora [1, 10] . In light of this, we investigated the possibility of reciprocal interspecies exchange in vitro of altered target genes between S. pneumoniae and 5 species of viridans streptococci, S. mitis, S. oralis, S. sanguis, S. constellatus, and S. mutans. The 3 former have been implicated in reciprocal horizontal transfer of b-lactam resistance determinants in vivo [1, 10] .
Materials and Methods

Bacterial strains, growth conditions, and MIC determinations.
Streptococcal strains used in this study are: S. pneumoniae R6 [4] , S. mitis 103335 T (SM1; Institut Pasteur, Paris, France), S. mitis 10712 (SM2; NCTC), S. oralis 102922 T (SOr; Institut Pasteur), S. sanguis 55128 T (SSa; Institut Pasteur), S. constellatus 6713 (SCo) clinical isolate (Hô pital Saint-Joseph, Paris), and S. mutans 103694 (SMu; Institut Pasteur). Most of the streptococcal strains used in this study were identified to the species level by sequencing the gene of the manganese-dependent superoxide dismutase [11] . Strains were grown at 37ЊC, either in Todd-Hewitt broth (Difco, Detroit) supplemented with 0.5% yeast extract or in C-medium supplemented with 0.2% yeast extract, to obtain competent cells, and MICs were determined as described elsewhere [4] . Spontaneous FQ-resistant mutants of streptococci were isolated as described elsewhere for S. pneumoniae [4] . Isolation of DNA and transformation experiments. DNA from S. pneumoniae was prepared and transformation carried out as described elsewhere [4] . DNA from the other species of streptococci was obtained from bacteria collected from 2 fresh agar plates as described elsewhere [12] . By use of the wild-type S. pneumoniae strain R6 as recipient, chromosomal DNA of FQ-resistant mutants of streptococci was added to the mixture at 0.5-1 mg/mL. Transformants expressing low-level resistance were selected on blood agar plates containing 16 or 20 mg/mL of pefloxacin (Rhô ne-Poulenc Rorer, Vitry-sur-Seine, France), and those expressing high-level resistance were selected on 2 mg/mL of sparfloxacin (Rhô ne-Poulenc Rorer). Reciprocal experiments with streptococcal wild-type strains as recipients and donor DNA from the low-level FQ-resistant S. pneumoniae transformant R6trLL R6p16 (harboring 1 mutation in ParC) [4] were performed by use of pefloxacin (20 mg/mL) as the selector.
Polymerase chain reaction (PCR) and sequencing experiments. Primers PNC10/PNC11 [4] were used to amplify a 346-pb fragment encompassing the parC QRDR of viridans streptococci. For S. constellatus, specific primers, SCC1 (5 -CTATGAATAAGGA-CGGCA-3 ) and SCC2 (5 -CAAAGTTCCAAGCAAAAGG-3 ; positions 139-157 and 436-418, respectively, S. pneumoniae numbering [5] ) were used. Primers PNC6/PNC7 [4] were used to amplify the QRDR of gyrA of S. mitis (251 bp). PCR was carried out as described elsewhere [4] . Direct sequencing of DNA fragments was done with the fmol DNA cycle sequencing system (Promega, Madison, WI) and the oligonucleotides used for amplification. A 4.2kb parE-parC region of the S. mitis strain 103335 T (SM1) was sequenced by "DNA walking," with an ABI PRISM 310A analyzer (Perkin-Elmer, Foster City, CA) by use of the dRhodamine terminator cycle sequencing ready reaction kit (Perkin-Elmer). This region was sequenced by use of 1 primer specific for S. mitis, SMC-E (5 -CAGACGGTGCCCACATTCA-3 ), from positions 1530 to 1549 of parE and by PNC14 (5 -TGACACCTGCTGCCTTAG-3 ) from positions 2051 to 2032 of parC (S. pneumoniae numbering [5] ). The end of parC was obtained by use of 1 parC-specific primer of S. mitis, SMC11 (5 -TTTGCTGCGACTCGTCTC-3 ; positions 1816-1834), and the primer PNC24 (5 -AACTTATTCTTCAT-TTC-3 ), corresponding to positions 20-3 upstream of the stop codon of parC of S. pneumoniae [5] . Transcriptional start sites for parC of S. mitis strain SM1 were identified by primer extension analysis according to standard protocols [12] with 5 -GGTCTT-GAATAATGTACTTGGAGTAGCGAC-3 .
Nucleotide sequence accession numbers. The DNA sequences reported in this paper have been assigned the following GenBank accession numbers: AF129757, AF129760, AF129759, AF129758, AF129761, AF129763, and AF129764.
Results
Selection and characterization of spontaneous FQ-resistant mutants. The MICs of different FQs are shown in table 1. One-step mutants from each wild-type strain were obtained by use of pefloxacin (16 mg/mL) as the selector, because the primary target of this FQ is clearly the ParC subunit of topoisomerase IV [4] . All mutants, except SM1-P16 5 , were generally characterized by a 4-to 16-fold increase in the MICs of pefloxacin and a 2-to 4-fold increase of ciprofloxacin and the most recent FQs, sparfloxacin, trovafloxacin, and grepafloxacin.
The QRDR sequences from position 165 (amino acid 56) to 387 (amino acid 129, S. pneumoniae numbering [5] ) of the parC genes of S. oralis, S. mitis SM1 and SM2, S. sanguis, and S. constellatus were determined. The nucleotide sequence homologies between these QRDRs and that of S. pneumoniae were, respectively, 95%, 91%, 91%, 85%, and 81%. A homology of 95% was found for the 2 strains of S. mitis. The amino acid identities were surprisingly high (197%). Wild-type ParC streptococcal sequences, with the exception of S. pneumoniae, contained an aspartate instead of an asparagine at position 91 (table 2). In S. sanguis and S. constellatus, a glycine instead of a serine was found at position 58. An additional difference was found in S. sanguis compared with S. pneumoniae: a methionine instead of an isoleucine at position 126. As expected from the low-level resistance expressed by the first-step mutants of viridans streptococci selected on pefloxacin, sequencing revealed 1 mutation in the QRDRs of ParC, at position 79 or 83 (table 2) previously identified in S. pneumoniae [4, 6, 7] . The substitution found in the QRDR of ParC in SM1-P16 5 was a novel mutation Ala63Val, with no mutation in the QRDR of gyrA. Transformation experiments and resistance phenotypes of transformants. To assess the possibility of genetic exchange between different streptococcal species, we tried to obtain FQresistant transformants of wild-type S. pneumoniae R6 by use of DNA from resistant mutants of viridans streptococci as donors. By use of DNA from pefloxacin-resistant mutants of S. mitis (SM1-P16 1 , SM1-P16 5 , and SM2-P16) or S. oralis (SOr-P16), pefloxacin-resistant transformants (R6tr) were obtained at frequencies of 10 Ϫ3 to . These were only 10-fold lower Ϫ3 5 ϫ 10 than those obtained when total pneumococcal DNA from FQresistant mutants with only 1 resistance marker (mutation in parC) was used as the donor [4] . When DNA from a pefloxacinresistant mutant of S. sanguis (SSa-P16) was used, transformants were obtained at frequencies of about . In con-Ϫ5 5 ϫ 10 trast, with S. constellatus (SCo-P16) DNA, R6 transformants were obtained only at very low frequencies (!10 Ϫ7 ). Except for this last case, these frequencies were higher than those of spontaneous mutants (!10 Ϫ7 ). For all the transformants, the MICs of the different FQs increased, as expected, 2-to 8-fold ( To further test the possible acquisition of FQ resistance by genetic exchange between viridans streptococci and S. pneu-moniae, we selected a high-level resistant mutant, SM1-HL1, from the low-level resistant S.mitis mutant SM1-P16 1 , on sparfloxacin (2 mg/mL; table 1). In addition to its ParC mutation Asp83Asn, SM1-HL1 had a GyrA Ser81Tyr mutation at the position analogous to serine 83 in Escherichia coli [9] . By use of its chromosomal DNA, it was possible to select high-level resistant transformants directly from R6, yet at a low frequency of about 10 Ϫ6 .
To verify that the FQ-resistant transformants of S. pneumoniae R6 obtained with DNA from the different FQ-resistant streptococci were in fact transformants and not spontaneous mutants, we sequenced the QRDRs of the parC genes of all R6 transformants presented in table 1 (see table 2 ), as well as the QRDRs of the parC and gyrA genes of the transformant R6trSM1-HL1 (data not shown). In each case, especially for R6trSCo-P16, the particular mutations responsible for resistance and the donor-specific nucleotides testified that they were true transformants.
Sequence analysis and genomic organization of the parE-parC region of S. mitis SM1. Since FQ-resistant transformants of S. pneumoniae R6 and S. mitis SM1 could be obtained in reciprocal experiments, we thought that a high degree of homology and a similar gene organization might exist between these 2 species with respect to the parE-parC region. The nucleotide and amino acid sequences of the 4.2-kb parE-parC region of SM1 showed 3 ORFs in the same orientation: first, the 3 -terminal 705 bp of parE,, which showed 91% homology with that of S. pneumoniae; then, 15 bp downstream of the stop codon of parE, an ORF of 831 bp, which shared 53% nucleotide sequence homology with the aminoglycoside adenylyltransferase (ANT) previously described in Bacillus subtilis Marburg [13] ; and finally parC, which shared 92% with parC of S. pneumoniae [5] . Deduced amino acid identities were, respectively, 99% for the C-terminal section of ParE and 96% for ParC. If the "ANT-like" gene, which was not associated with any particular phenotype in S. mitis SM1, was excluded, the intergenic region of S. pneumoniae (419 bp) [5] was longer than that of S. mitis (245 bp), and the 230 bp upstream from the start codon of parC in the 2 species showed a homology of 82%.
Primer extension analysis revealed multiple transcriptional start sites for parC in S. mitis, including A1643, T1664, and T1719, downstream from the ANT-like gene. None was compatible with the promoter suggested previously for parC in the homologous region of S. pneumoniae [7] .
Discussion
Because the natural transformation is the major contributor to the b-lactam resistance in S. pneumoniae as well as in viridans streptococci [1, 10] , we explored the possibility of transfer of quinolone resistance determinants in vitro, by transformation with DNA from S. pneumoniae itself and from streptococci generally living in the same habitat.
Transformants were obtained with DNA from resistant mutants of S. oralis, S. mitis, S. sanguis, and S. constellatus at decreased frequencies, which correlated well with the decreased nucleotide sequence homologies of their parC genes. Moreover, the frequencies of transformation correlated with the SOD gene sequences of these species, and this probably explains why FQ resistance could not be transferred from S. mutans, which is only distantly related with pneumococcus [11] . The moderate frequencies observed in the reciprocal experiment could be explained by the experimental conditions to obtain competent cells, which were optimized for S. pneumoniae. Not surprisingly, in all transformants a part of the mutated parC gene was integrated intact, as suggested by the complete identity between the QRDR fragments sequenced from the donor and the transformant. This phenomenon is reminiscent of what is found in the mosaic PBP genes associated with b-lactam resistance in these species [1, 10] . When a double ParC-GyrA high-level resistant mutant of S. mitis was used as a DNA donor, high-level FQ-resistant transformants of S. pneumoniae R6 were obtained only at low frequencies, corresponding to those expected for the transfer of 2 unlinked genes. The situation is similar to that observed for intraspecific transfer of mutated parC and gyrA genes of S. pneumoniae [4, 7] .
Even though the transformations in vivo were less efficient than in vitro, high frequencies observed in these experiments suggested that reciprocal transfer of FQ resistance determinants between S. pneumoniae and viridans streptococci are very likely to occur in vivo. Once point mutations occur in the topoiso-merase IV alone or associated with mutations in the gyrase genes of these species, as it has already occurred after treatment with older FQs [2, 4, 7, 14] , genetic exchanges under the selective pressure of these antibiotics would propagate the resistance.
While this work was in progress, FQ resistance determinants from clinical isolates of some viridans streptococci have been transferred to pneumocci by transformation in vitro [14] .
